[Hyp3]-tuftsin ([Hyp3]-TU) synthesis and biological activity. 1991

U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
Department of Pharmacology Silesian Academy of Medicine, Zabrze.

[Hyp3]-tuftsin (Thr-Lys-Hyp-Arg) has been synthesized by the liquid-phase method. In biological investigations performed on rats antinociceptive and diuretic effects have been determined. It has been suggested that the presence of hydroxyl substituent in pyrrolidine ring of proline slightly modifies antinociceptive TU effect and is responsible for the increased diuretic [Hyp3]-TU activity.

UI MeSH Term Description Entries
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009619 Nociceptors Peripheral AFFERENT NEURONS which are sensitive to injuries or pain, usually caused by extreme thermal exposures, mechanical forces, or other noxious stimuli. Their cell bodies reside in the DORSAL ROOT GANGLIA. Their peripheral terminals (NERVE ENDINGS) innervate target tissues and transduce noxious stimuli via axons to the CENTRAL NERVOUS SYSTEM. Pain Receptors,Receptors, Pain,Nociceptive Neurons,Neuron, Nociceptive,Neurons, Nociceptive,Nociceptive Neuron,Nociceptor,Pain Receptor
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014405 Tuftsin N(2)-((1-(N(2)-L-Threonyl)-L-lysyl)-L-prolyl)-L-arginine. A tetrapeptide produced in the spleen by enzymatic cleavage of a leukophilic gamma-globulin. It stimulates the phagocytic activity of blood polymorphonuclear leukocytes and neutrophils in particular. The peptide is located in the Fd fragment of the gamma-globulin molecule. L-Thr-L-Lys-L-Pro-L-Arg,L-Threonyl-L-Lysyl-L-Prolyl-L-Arginine,Taftsin
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
January 1984, Peptides,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
April 2011, Journal of medicinal chemistry,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
December 1981, Molecular and cellular biochemistry,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
January 1983, Archivum immunologiae et therapiae experimentalis,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
January 1983, Annals of the New York Academy of Sciences,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
January 1978, Archivum immunologiae et therapiae experimentalis,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
February 1987, International journal of peptide and protein research,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
August 1983, Biochemical and biophysical research communications,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
December 2015, European journal of medicinal chemistry,
U Galasik-Bartoszek, and D Konopińska, and A Plech, and V A Najjar, and R Brus
December 2011, Biomaterials,
Copied contents to your clipboard!